Insight Molecular Diagnostics Inc. Marketable Securities, Unrealized Gain (Loss)
Insight Molecular Diagnostics Inc. (IMDX) reported Marketable Securities, Unrealized Gain (Loss) of -$61.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2025-03-24
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-12-31 was -$69.00K, a 592.86% decline year-over-year.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-09-30 was -$89.00K.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-06-30 was -$24.00K, a 580.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-03-31 was $121.00K.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was -$61.00K.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was -$471.00K, a 305.68% decline from fiscal 2021.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for fiscal 2021 was $229.00K, a 22.90% decline from fiscal 2020.
- Insight Molecular Diagnostics Inc. marketable securities, unrealized gain (loss) for fiscal 2020 was $297.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$158.00K derived: sum of 2 quarters · filed 2025-03-24 | -$182.00K derived: sum of 3 quarters · filed 2025-03-24 | -$61.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$89.00K 10-Q · filed 2024-11-12 | -$113.00K derived: sum of 2 quarters · filed 2024-11-12 | $8.00K 10-Q · filed 2024-11-12 | $22.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$24.00K 10-Q · filed 2024-08-08 | $97.00K 10-Q · filed 2024-08-08 | $111.00K derived: sum of 3 quarters · filed 2024-08-08 | -$49.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $121.00K 10-Q · filed 2024-05-15 | $135.00K derived: sum of 2 quarters · filed 2024-05-15 | -$25.00K derived: sum of 3 quarters · filed 2024-05-15 | -$20.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$146.00K derived: sum of 2 quarters · filed 2023-11-09 | -$141.00K derived: sum of 3 quarters · filed 2023-11-09 | -$471.00K 10-K · filed 2023-04-12 |
| 2022-09-30 | -$160.00K 10-Q · filed 2023-11-09 | -$155.00K derived: sum of 2 quarters · filed 2023-11-09 | -$485.00K 10-Q · filed 2023-11-09 | -$504.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-10 | -$325.00K 10-Q · filed 2023-08-10 | -$344.00K derived: sum of 3 quarters · filed 2023-08-10 | -$482.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$330.00K 10-Q · filed 2023-05-15 | -$349.00K derived: sum of 2 quarters · filed 2023-05-15 | -$487.00K derived: sum of 3 quarters · filed 2023-05-15 | -$314.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$157.00K derived: sum of 2 quarters · filed 2023-04-12 | $16.00K derived: sum of 3 quarters · filed 2023-04-12 | $229.00K 10-K · filed 2023-04-12 |
| 2021-09-30 | -$138.00K 10-Q · filed 2022-11-10 | $35.00K derived: sum of 2 quarters · filed 2022-11-10 | $248.00K 10-Q · filed 2022-11-10 | $563.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $173.00K 10-Q · filed 2022-08-12 | $386.00K 10-Q · filed 2022-08-12 | $701.00K derived: sum of 3 quarters · filed 2022-08-12 | $721.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $213.00K 10-Q · filed 2022-05-12 | $528.00K derived: sum of 2 quarters · filed 2022-05-12 | $548.00K derived: sum of 3 quarters · filed 2022-05-12 | $564.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $335.00K derived: sum of 2 quarters · filed 2022-03-11 | $351.00K derived: sum of 3 quarters · filed 2022-03-11 | $297.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $20.00K 10-Q · filed 2021-11-09 | $36.00K derived: sum of 2 quarters · filed 2021-11-09 | -$18.00K 10-Q · filed 2021-11-09 | -$53.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $16.00K 10-Q · filed 2021-08-11 | -$38.00K 10-Q · filed 2021-08-11 | -$73.00K derived: sum of 3 quarters · filed 2021-08-11 | -$176.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$53.00K 10-Q · filed 2021-05-17 | -$89.00K derived: sum of 2 quarters · filed 2021-05-17 | -$192.00K derived: sum of 3 quarters · filed 2021-05-17 | -$280.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$139.00K derived: sum of 2 quarters · filed 2021-03-19 | -$227.00K derived: sum of 3 quarters · filed 2021-03-19 | -$49.00K 10-K · filed 2021-03-19 |
| 2019-09-30 | -$103.00K 10-Q · filed 2020-11-12 | -$191.00K derived: sum of 2 quarters · filed 2020-11-12 | -$13.00K 10-Q · filed 2020-11-12 | -$511.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$88.00K 10-Q · filed 2020-07-29 | $90.00K 10-Q · filed 2020-07-29 | -$408.00K derived: sum of 3 quarters · filed 2020-07-29 | -$306.00K derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $178.00K 10-Q · filed 2020-05-12 | -$320.00K derived: sum of 2 quarters · filed 2020-05-12 | -$218.00K derived: sum of 3 quarters · filed 2020-05-12 | -$441.00K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | -$498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$396.00K derived: sum of 2 quarters · filed 2020-03-26 | -$619.00K derived: sum of 3 quarters · filed 2020-03-26 | -$427.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $102.00K 10-Q · filed 2019-11-14 | -$121.00K derived: sum of 2 quarters · filed 2019-11-14 | $71.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$223.00K 10-Q · filed 2019-08-14 | -$32.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $190.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |